6472

COM:BORA-CORP

Bora Pharmaceuticals

Stock

Last Close

793.00

21/11 05:30

Market Cap

86.08B

Beta: -

Volume Today

1.39M

Avg: -

Overview Analysis Metrics Financials Filings people API Chart Data

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Dec '21	Dec '22	Dec '23
revenue	4.90B -	10.49B 114.18%	14.20B 35.31%
cost of revenue	3.23B -	7.58B 134.87%	7.21B 4.92%
gross profit	1.67B -	2.91B 74.23%	6.99B 140.02%
selling and marketing expenses	178.36M -	260.12M 45.84%	447.09M 71.88%
general and administrative expenses	406.16M -	601.41M 48.07%	996.85M 65.75%
selling general and administrative expenses	584.52M -	861.52M 47.39%	1.44B 67.60%
research and development expenses	41.27M -	129.08M 212.79%	298.16M 130.99%
other expenses	31.59M -	26.55M 15.96%	-1.01B 3,917.99%
cost and expenses	3.85B -	8.57B 122.43%	8.95B 4.42%
operating expenses	625.79M -	990.60M 58.30%	1.74B 75.86%
interest expense	53.62M -	108.73M 102.79%	171.24M 57.49%
ebitda	1.29B -	2.27B 76.58%	4.84B 112.92%
operating income	1.08B -	1.95B 80.84%	4.24B 117.34%
depreciation and amortization	210.16M -	325.19M 54.73%	606.29M 86.44%
total other income expenses net	-53.62M -	-108.73M 102.79%	-171.24M 57.49%
income before tax	1.02B -	1.84B 79.69%	4.06B 120.88%
income tax expense	274.23M -	438.48M 59.89%	992.23M 126.29%
net income	749.74M -	1.39B 85.65%	3.03B 117.70%
weighted average shs out	77.85M -	97.60M 25.37%	100.34M 2.81%
weighted average shs out dil	78.08M -	98.70M 26.40%	103.56M 4.93%
eps	7.73 -	14.26 84.48%	30.20 111.78%
epsdiluted	7.71 -	14.13 83.27%	29.39 108.00%

All numbers in (except ratios and percentages)